bepafant has been researched along with Hypersensitivity, Type III in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jancar, S; Russo, M; Starobinas, N; Steil, AA; Tavares de Lima, W; Teixeira, CF | 1 |
| Jancar, S; Steil, AA; Tavares de Lima, W | 1 |
2 other study(ies) available for bepafant and Hypersensitivity, Type III
| Article | Year |
|---|---|
Lipid mediators, tumor necrosis factor and nitric oxide and their interactions in immune-complex-induced lung injury.
Topics: Animals; Azepines; Bronchoalveolar Lavage Fluid; Immune Complex Diseases; Leukotriene B4; Lung; Male; Neutrophils; Nitric Oxide; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Triazoles; Tumor Necrosis Factor-alpha | 1998 |
Modulation by lipid mediators of immune complex-induced lung inflammation in mice.
Topics: Animals; Antigen-Antibody Complex; Arthus Reaction; Azepines; Benzopyrans; Blood Vessels; Bronchoalveolar Lavage Fluid; Capillary Permeability; Dose-Response Relationship, Drug; Eicosanoids; Hemoglobins; Immune Complex Diseases; Indoles; Indomethacin; Lipoxygenase Inhibitors; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neutrophils; Peroxidase; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pneumonia; Receptors, Leukotriene B4; Species Specificity; Triazoles | 1998 |